Science roundupFriday 23 October 2026

Warhound's $200M war dogs lead today's science

Science today is split between biology pushed into new territory and infrastructure being rebuilt under pressure. The biggest story is a $200 million bet on genetically engineered war dogs, which raises questions about how far bioengineering should go. Meanwhile, a Ukrainian radio telescope is getting a second life, and an mRNA cancer vaccine clears a late-stage hurdle.

In today's edition: Bioengineering's sharp edge and Science under fire, plus quick bites.

Bioengineering's sharp edge

Two stories today push biology into contested territory: one commercializes engineered animals for combat, the other edges closer to personalized cancer treatment.

Science under fire

From a war-torn telescope to a space program juggling risk, these stories show infrastructure and missions straining under real-world pressure.

Quick bites